Cancer Research UK Cambridge Institute shared a post on LinkedIn:
“It is with profound sadness that we share the news of the passing of Professor Greg Hannon, who led the Cancer Research UK Cambridge Institute for over eight years.
Greg was already a world-renowned scientist when appointed Director, and for the community, he was a visionary leader, a cherished mentor, and a singular force of nature whose influence shaped the research landscape.
During his tenure, Greg led significant growth at the Institute, expanding faculty appointments, strengthening partnerships, establishing the Spatial Profiling and Annotation Centre of Excellence and securing £173 million for the Institute’s future. His inspirational leadership was vital in our response to COVID-19, setting up a diagnostics lab to support Addenbrooke’s Hospital during a critical and unpredictable period of the pandemic.
Beyond his international recognition, those of us who had the privilege of knowing Greg will remember him for his remarkable and unique intelligence, his good humour, and his sharp wit.
Greg believed that the greatest breakthroughs did not come from equipment or funding, but from the strength of community. He had a gift for making everyone, from PhD students to senior faculty, feel welcomed and heard.
At the heart of his leadership was a deep commitment to training the next generation of scientists, with the many students, post doctorates and support staff he mentored over the years standing as a testament to his lasting impact. There exists a worldwide family of Hannon Lab members, and adopted members, brought together by his lifelong dedication, generosity and support.
You can read our full tribute here.”
Samra Turajlić, Director at CRUK Manchester Institute, shared the post, adding:
“We are deeply saddened by the passing of Professor Greg Hannon. His loss will be felt profoundly across the global cancer research community and especially the whole of Cancer Research UK (CRUK) community.
Greg was an exceptional scientist, an inspiring leader whose vision and dedication transformed the Cancer Research UK Cambridge Institute during his tenure. His commitment to advancing discovery, fostering collaboration, and investing in people resonates strongly with our own values at Cancer Research UK Manchester Institute.
Greg’s legacy extends far beyond Cambridge. Many in our community have been influenced, directly or indirectly, by his work, his leadership, and the remarkable network of scientists he nurtured throughout his career. Personally I hugely appreciated Greg’s kindness and support since taking up a leadership role.
At this difficult time, our thoughts are with Greg’s family, friends, colleagues, and the extended Hannon Lab community around the world. There is no doubt that Greg’s contributions to science and to the people within it will continue to inspire future generations.”
Other articles on OncoDaily.